Skip to main content

Table 1 Baseline characteristics of the study population

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Demographics  
 Mean age (years) 50 ± 12 (20–77)
 Male sex 74 % (88)
HCV genotype  
 1a 20 % (23)
 1b 44 % (53)
 2 12 % (14)
 3 20 % (24)
 4 4 % (5)
Mean HCV-RNA (10E6 IU ml-1) 3.23 ± 6.61 (0.02–34.50)
Cirrhosis 46 % (55)
Treatment history  
 Treatment naive 50 % (59)
 Treatment experienced 50 % (60)
 Protease inhibitor experienced 23 % (27)
Clinical chemistry  
 Platelets (10E3 μl-1) 155 ± 74 (13–396)
 Total bilirubin (mg dl-1) 1.0 ± 0.8 (0.2–4.7)
 INR 1.09 ± 0.25 (0.84–2.65)
 Creatinine (mg dl-1) 0.78 ± 0.21 (0.43–1.85)
  1. Data are expressed as percent (number) or means ± SD (range)